Zealand Pharma Retained Earnings (Accumulated Deficit) 2017-2024 | ZLDPF
Zealand Pharma retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-0.868B, a 440.5% decline year-over-year.
- Zealand Pharma retained earnings (accumulated deficit) for 2023 were $-0.711B, a 769.6% decline from 2022.
- Zealand Pharma retained earnings (accumulated deficit) for 2022 were $0.106B, a 120.17% decline from 2021.
- Zealand Pharma retained earnings (accumulated deficit) for 2021 were $-0.526B, a 50.02% increase from 2020.